PRAD1/Cyclin D1 Gene Overexpression in Mantle Cell Lymphoma
- 1 January 1996
- journal article
- research article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 21 (1-2) , 37-42
Abstract
The t(11;14) (q13;q32) translocation and its molecular counterpart Bcl-1 rearrangement are consistent features of mantle cell lymphoma (MCL). This translocation activates the PRAD1/cyclin D1 gene that is considered to be the Bcl-1 oncogene. PRAD1/cyclin D1 gene overexpression is closely associated with MCL. The PRAD1/cyclin D1 protein is localized to the nucleus, and the strong correlation between PRAD1/cyclin D1 and MCL is also found in the protein level. This finding indicates that PRAD1/cyclin D1 expression is a highly specific and sensitive molecular marker for MCL. This gene may function as an oncogene in the malignant transformation of cells.Keywords
This publication has 41 references indexed in Scilit:
- PRAD1 gene over‐expression in mantle‐cell lymphoma but not in other low‐grade B‐cell lymphomas, including extranodal lymphomaBritish Journal of Haematology, 1994
- Cyclin D1 is a nuclear protein required for cell cycle progression in G1.Genes & Development, 1993
- PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma.Proceedings of the National Academy of Sciences, 1991
- Human D-type cyclinCell, 1991
- A novel cyclin encoded by a bcl1-linked candidate oncogeneNature, 1991
- Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma.Journal of Clinical Investigation, 1989
- Human HST1 (HSTF1) gene maps to chromosome band 11q13 and coamplifies with the INT2 gene in human cancer.Proceedings of the National Academy of Sciences, 1988
- Mantle-zone lymphoma: A follicular variant of intermediate lymphocytic lymphomaCancer, 1982
- A new characteristic karyotypic anomaly in lymphoproliferative disordersCancer, 1979
- Histopathology of malignant lymphomasClinics in Haematology, 1974